Labshake search
Citations for R&D Systems :
401 - 450 of 2503 citations for Recombinant Human FCAR His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2024Quote: ... and recombinant human or murine Fc-ICAM-1 (10 μg/ml) (R&D Systems) coated plates ...
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-4 (R&D systems, #204-IL/CF). Inhibitors used were the PI3Kdelta inhibitor Idelalisib ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 μM Y-27632 and 2 ng/mL human recombinant BMP4 (R&D Systems) and then cultured in ultra-low attachment 6 well plate (Corning ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Microbiology 2023Quote: ... Recombinant human Wnt-3a (rhWnt-3a) (#5036-WN, R&D Systems; Minneapolis, Minnesota, USA) was resuspended according to manufacturer’s instructions and stored at −80°C.
-
ANGPTL8 R59W variant influences inflammation through modulating NF-κB pathway under TNFα stimulationbioRxiv - Biochemistry 2023Quote: ... the cells were treated with Recombinant Human TNFα Protein (R&D Systems, MN, USA) at 25ng/mL for 18 hours ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 ng mL− 1 BMP-4 (human recombinant) (R&D Systems, Minneapolis, MN, USA), 10 µM LY294002 (Cayman Chemical ...
-
bioRxiv - Genetics 2023Quote: ... and recombinant human FGF2 at 20 ng/uL (R&D systems #233-FB-010).
-
bioRxiv - Cancer Biology 2023Quote: ... and 100 ng/mL of recombinant human IL-17B (R&D Systems, Minneapolis, MN) for 48 h and processed for downstream RNA expression analysis ...
-
bioRxiv - Biochemistry 2023Quote: ... we used commercial recombinant human OGT fragment (Cys323-Glu1041) (R&D systems, 8446-GT). Thereafter ...
-
bioRxiv - Cancer Biology 2023Quote: ... 200ng/mL recombinant Human Wnt3a (R&D System, Cat. No. 5036-WN-010/CF) or Wnt5a (R&D System ...
-
bioRxiv - Immunology 2023Quote: ... and 1 ng/ml recombinant human basic fibroblast growth factor (bFGF)(R&D Systems). Human MSCs were obtained from ATCC (catalog #PCS-500-012 ...
-
bioRxiv - Bioengineering 2023Quote: ... 1.5 mL CDM with 6 ng/mL human recombinant activin A (R&D Systems) and 5 ng/mL bFGF (R&D Systems ...
-
bioRxiv - Biochemistry 2023Quote: Recombinant human angiogenin (catalog number 265-AN/CF) was purchased from R&D Systems, a Bio-Techne Company (Minneapolis ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 20 ng/mL of recombinant human oncostatin M (OSM, R&D systems). For the co-culture experiment ...
-
bioRxiv - Molecular Biology 2024Quote: ... with or without 1 ng/mL recombinant human BMP9 (R&D Systems, Minneapolis, MN) for an additional 24 hours ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-7 (rh IL-7; R&D Systems). PBMCs treated with 0.1ug/mL of SEB were supplemented with 10ng/mL of rh IL-7 alone ...
-
bioRxiv - Biochemistry 2020Quote: In vitro co-precipitation of TREM2 or TREM1 with Aβ oligomers was performed by mixing recombinant Fc-tagged TREM2 or TREM1 ectodomain (residues 19-171; 100 ng/ml, R&D systems), 100 nM HiLyte Fluor 647-labelled Aβ oligomers and Protein G Dynabeads in 0.5% fatty acid free BSA PBS-Tween buffer ...
-
bioRxiv - Developmental Biology 2019Quote: ... 0.01% of recombinant human FGF basic protein 10μg/ml (R&D Systems, #233-FB-025).
-
bioRxiv - Bioengineering 2021Quote: Recombinant human IDO expressed in Escherichia coli was purchased from R&D Systems (Minneapolis, MN) with a predicted molecular mass of 46 kDa a specific activity of >500pmoles/min/μg (or for equimolar calculations >29 pmol NFK/min/pmol IDO ...
-
bioRxiv - Cancer Biology 2020Quote: ... 10 ng/ml IL6 + 0.1 ng/ml recombinant human sgp130-Fc (R&D Systems, Germany) or 20 ng/ml Hyper-IL6 (kind gift of S ...
-
bioRxiv - Microbiology 2020Quote: ... infected HFF monolayers were stimulated with 100U/mL recombinant human IFN-γ (R&D Systems) 24 hours post-infection and fixed 6 hours post-stimulation ...
-
bioRxiv - Cancer Biology 2020Quote: ... CMK lines were treated with 200 ng/ml of recombinant human WNT3A (R&D systems) for 4 hours ...
-
bioRxiv - Cancer Biology 2021Quote: ... 10 ng ml−1 of recombinant human TNFα (R&D Systems, 210-TA-020/CF) or a combination of both ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 ng/ml recombinant human NRG1-β 1 (#396-HB, R&D Systems, USA) as described in Poitelon et al ...
-
bioRxiv - Molecular Biology 2022Quote: Human recombinant BMP-2 and BMP-4 were purchase from R&D Systems (Minneapolis, MN). Anti-Myc and anti-HA antibodies were purchased from Cell Signaling Technology (Danvers ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human versican isoform V3 and lumican were from R&D Systems (Minneapolis, MN, USA). Recombinant human versican protein G1 and G3 domains (ab152303 and ab236178 ...
-
bioRxiv - Molecular Biology 2020Quote: Mice fibroblast cells (FLS) treated with 5 ng/mL recombinant human TNF (R&D Systems) for 16 hours were harvested at 95% confluence ...
-
bioRxiv - Immunology 2022Quote: ... 625 or 312.5 ng/mL recombinant human IL13Rα1-Fc chimera (R&D Systems Cat#146IR) or IL13Rα2-Fc chimera ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant epidermal growth factor (20 ng/ml; #236-EG-01M, R&D systems, USA), human recombinant fibroblast growth factor (20 ng/ml ...
-
bioRxiv - Pathology 2019Quote: ... Human recombinant PDGF-BB and TNF-α were purchased from R&D Systems (Minneapolis, MN). TRIzol ...
-
bioRxiv - Immunology 2020Quote: ... Monocytes were stimulated for 18hrs with 100U/mL recombinant human IFN-β (R&D systems) and processed for RNA extraction.
-
bioRxiv - Cancer Biology 2019Quote: ... Recombinant Human EGF Protein 10 ng/mL (R&D systems, Cat. No. 236-EG-200), Recombinant Human FGF basic ...
-
bioRxiv - Molecular Biology 2020Quote: ... and BARD1 proteins was conducted using recombinant human ubiquitin (U-100H, R&D system, USA) and HeLa NE as a source of E1 and E2 ligases in 20 mM Tris-HCl pH 7.5 ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems; Bio-techne, Inc.) until use.
-
bioRxiv - Pathology 2021Quote: ... 25 μL of biotinylated recombinant human IL5 (rhIL5) protein (50 μg/mL) (R&D Systems) was added at 1:50 in PBS ...
-
bioRxiv - Physiology 2020Quote: ... with 2 µg of recombinant human TSG-6 (rTSG-6, R&D Systems, Minneapolis, MN) in 100 µl PBS (or with PBS alone ...
-
bioRxiv - Developmental Biology 2019Quote: ... 10 uM SB431542 (SA) and 10 ng/mL recombinant human FGF-2 (R&D Systems) were added on D2 for 2 days ...
-
bioRxiv - Genetics 2020Quote: ... base medium supplemented with 50 ng/ml recombinant human SCF (R&D systems #255-SC), 1 μg/ml doxycycline (Sigma Aldrich #D9891) ...
-
bioRxiv - Biochemistry 2021Quote: ... recombinant human CD45 (cat no. 1430-CD-050) was from R&D Systems (Minneapolis, MN), recombinant human CD45 (cat no ...
-
bioRxiv - Cancer Biology 2021Quote: ... Recombinant human TNFα protein (#210-TA-005) was purchased from R&D Systems (Minneapolis, USA).
-
bioRxiv - Cell Biology 2020Quote: ... with 25 ng/ml recombinant human WNT3A (R&D Systems, cat. no. 5036-WN-010) and 100 ng/ml Activin A (Humanzyme ...
-
bioRxiv - Immunology 2020Quote: ... Recombinant human IL-15 and mouse IL-21 were from R&D Systems (Minneapolis, MN).
-
bioRxiv - Immunology 2020Quote: ... CF (uPA) and Recombinant human NKG2D/CD314 Fc Chimera were purchased from R&D systems. Biotin-Protein L was purchased from GenScript ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 50 ng/mL recombinant human vascular endothelial growth factor (VEGF; R&D Systems), 10 μM Y-27632 ...
-
bioRxiv - Cell Biology 2022Quote: ... they and their controls were treated with recombinant human CXCL12 (R&D Systems, #350-NS) in a biopolymer delivery vehicle (CellMate3D ...
-
bioRxiv - Immunology 2022Quote: ... or 10 ng/mL of recombinant human IL-1β (R&D Systems; 201-LB-005) for the indicated times ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 20 ng/mL recombinant human basic FGF (#233-FB, R&D Systems, Germany) and 10 µM Y-27632 (only for the first 24 h after passaging ...
-
bioRxiv - Systems Biology 2023Quote: ... with 10% Fetal Bovine Serum and 100ng/ml recombinant Human M-CSF (R&D Systems) for 4 days.